2006
Please click on the title to view the abstract and publication
source for each paper, as listed on 'www.pubmed.com'.
Chernobyl:
the true health and environmental legacy.
Arnold R, Holdstock M.
Med Confl Surviv. 2006 Oct-Dec;22(4):310-3.
Chernobyl--looking
back to go forwards: the September 2005 IAEA Conference.
Pflugbeil S.
Med Confl Surviv. 2006 Oct-Dec;22(4):299-309.
Chernobyl
and thyroid cancer.
Williams ED.
J Surg Oncol. 2006 Dec 15;94(8):670-7. Review.
Thyroid
cancer after exposure to radioactive 131I.
Holm LE.
Acta Oncol. 2006;45(8):1037-40.
A
cohort study of thyroid cancer and other thyroid diseases
after the Chornobyl accident: pathology analysis of thyroid
cancer cases in Ukraine detected during the first screening
(1998-2000).
Bogdanova TI, Zurnadzhy LY, Greenebaum E, McConnell RJ,
Robbins J, Epstein OV, Olijnyk VA, Hatch M, Zablotska
LB, Tronko MD.
Cancer. 2006 Dec 1;107(11):2559-66.
Radiation-induced
thyroid cancer: what we have learned from Chernobyl.
Nikiforov YE.
Endocr Pathol. 2006 Winter;17(4):307-17. Review.
Suicide
risk among chernobyl cleanup workers in estonia still
increased: an updated cohort study.
Rahu K, Rahu M, Tekkel M, Bromet E.
Ann Epidemiol. 2006 Dec;16(12):917-9.
Autoimmune
thyroiditis and exposure to iodine 131 in the Ukrainian
cohort study of thyroid cancer and other thyroid diseases
after the Chornobyl accident: results from the first screening
cycle (1998-2000).
Tronko MD, Brenner AV, Olijnyk VA, Robbins J, Epstein
OV, McConnell RJ, Bogdanova TI, Fink DJ, Likhtarev IA,
Lubin JH, Markov VV, Bouville AC, Terekhova GM, Zablotska
LB, Shpak VM, Brill AB, Tereshchenko VP, Masnyk IJ, Ron
E, Hatch M, Howe GR.
J Clin Endocrinol Metab. 2006 Nov;91(11):4344-51.
131I
ablation treatment in young females after the Chernobyl
accident.
Travis CC, Stabin MG.
J Nucl Med. 2006 Oct;47(10):1723-7. Erratum in: J Nucl
Med. 2007 Jan;48(1):7.
A
perspective on post-Chernobyl radioablation in young females.
Reiners C, Lassmann M, Hänscheid H.
J Nucl Med. 2006 Oct;47(10):1563-4.
The
chernobyl accident 20 years on: an assessment of the health
consequences and the international response.
Baverstock K, Williams D.
Environ Health Perspect. 2006 Sep;114(9):1312-7.
Molecular
cytogenetic characterization of chromosome 9-derived material
in a human thyroid cancer cell line.
Weier HU, Tuton TB, Ito Y, Chu LW, Lu CM, Baumgartner
A, Zitzelsberger HF, Weier JF.
Cytogenet Genome Res. 2006;114(3-4):284-91.
Microarray
comparative genomic hybridization reveals genome-wide
patterns of DNA gains and losses in post-Chernobyl thyroid
cancer.
Kimmel RR, Zhao LP, Nguyen D, Lee S, Aronszajn M, Cheng
C, Troshin VP, Abrosimov A, Delrow J, Tuttle RM, Tsyb
AF, Kopecky KJ, Davis S, Neiman PE.
Radiat Res. 2006 Sep;166(3):519-31.
Radiation
exposure and thyroid cancer.
Hoffman FO, Ruttenber AJ, Greenland S, Carroll RJ.
JAMA. 2006 Aug 2;296(5):513; author reply 514.
Post-Chernobyl
thyroid cancers in Ukraine. Report 2: risk analysis.
Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Ron E, Lubin
J, Bouville A, Tronko N, Bogdanova T, Gulak L, Zablotska
L, Howe G.
Radiat Res. 2006 Aug;166(2):375-86.
Childhood
thyroid cancer, radiation dose from Chernobyl, and dose
uncertainties in Bryansk Oblast, Russia: a population-based
case-control study.
Kopecky KJ, Stepanenko V, Rivkind N, Voillequé P, Onstad
L, Shakhtarin V, Parshkov E, Kulikov S, Lushnikov E, Abrosimov
A, Troshin V, Romanova G, Doroschenko V, Proshin A, Tsyb
A, Davis S.
Radiat Res. 2006 Aug;166(2):367-74.
Cancer
risk among Chernobyl cleanup workers in Estonia and Latvia,
1986-1998.
Rahu M, Rahu K, Auvinen A, Tekkel M, Stengrevics A, Hakulinen
T, Boice JD Jr, Inskip PD.
Int J Cancer. 2006 Jul 1;119(1):162-8.
Somatic
mutagenesis at T-cell receptor locus in inhabitants of
radiation polluted regions as a result of the Chernobyl
disaster.
Zamulaeva IA, Smirnova SG, Orlova NV, Vereshchagina OA,
Chekin SIu, Smirnova IA, Krikunova LI, Parshin VS, Ivanov
VK, Saenko AS.
Radiats Biol Radioecol. 2006 May-Jun;46(3):307-14. Russian.
The
effect of Chernobyl accident on the development of malignant
diseases--situation after 20 years.
Zonenberg A, Zarzycki W, Leoniak M.
Endokrynol Pol. 2006 May-Jun;57(3):244-52. Review. Polish.
A
cohort study of thyroid cancer and other thyroid diseases
after the chornobyl accident: thyroid cancer in Ukraine
detected during first screening.
Tronko MD, Howe GR, Bogdanova TI, Bouville AC, Epstein
OV, Brill AB, Likhtarev IA, Fink DJ, Markov VV, Greenebaum
E, Olijnyk VA, Masnyk IJ, Shpak VM, McConnell RJ, Tereshchenko
VP, Robbins J, Zvinchuk OV, Zablotska LB, Hatch M, Luckyanov
NK, Ron E, Thomas TL, Voillequé PG, Beebe GW.
J Natl Cancer Inst. 2006 Jul 5;98(13):897-903.
Questionnaire-
and measurement-based individual thyroid doses in Ukraine
resulting from the Chornobyl nuclear reactor accident.
Likhtarev I, Bouville A, Kovgan L, Luckyanov N, Voillequé
P, Chepurny M.
Radiat Res. 2006 Jul;166(1 Pt 2):271-86.
The
chernobyl accident: estimation of radiation doses received
by the Baltic and Ukrainian cleanup workers.
Bouville A, Chumak VV, Inskip PD, Kryuchkov V, Luckyanov
N.
Radiat Res. 2006 Jul;166(1 Pt 2):158-67.
Measurement
of 129 I and 137 Cs in soils from Belarus and reconstruction
of 131I deposition from the Chernobyl accident.
Straume T, Anspaugh LR, Marchetti AA, Voigt G, Minenko
V, Gu F, Men P, Trofimik S, Tretyakevich S, Drozdovitch
V, Shagalova E, Zhukova O, Germenchuk M, Berlovich S.
Health Phys. 2006 Jul;91(1):7-19.
France.
Twenty years after Chornobyl, legal fallout lingers.
Enserink M.
Science. 2006 Jun 9;312(5779):1455.
Cancer
consequences of the Chernobyl accident: 20 years on.
Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville
A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch
V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P,
Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ,
Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi
M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita
S, Zvonova I.
J Radiol Prot. 2006 Jun;26(2):127-40. Review.
Re:
Risk of thyroid cancer after exposure to (131)I in childhood.
Grossman CM, Nussbaum RH.
J Natl Cancer Inst. 2006 May 3;98(9):641; author reply
641-2.
RET
rearrangements in post-Chernobyl papillary thyroid carcinomas
with a short latency analysed by interphase FISH.
Unger K, Zurnadzhy L, Walch A, Mall M, Bogdanova T, Braselmann
H, Hieber L, Tronko N, Hutzler P, Jeremiah S, Thomas G,
Zitzelsberger H.
Br J Cancer. 2006 May 22;94(10):1472-7.
No
increase in thyroid cancer among children and adolescents
in Finland due to Chernobyl accident.
But A, Kurttio P, Heinävaara S, Auvinen A.
Eur J Cancer. 2006 May;42(8):1167-71.
Estimates
of the cancer burden in Europe from radioactive fallout
from the Chernobyl accident.
Cardis E, Krewski D, Boniol M, Drozdovitch V, Darby SC,
Gilbert ES, Akiba S, Benichou J, Ferlay J, Gandini S,
Hill C, Howe G, Kesminiene A, Moser M, Sanchez M, Storm
H, Voisin L, Boyle P.
Int J Cancer. 2006 Sep 15;119(6):1224-35.
Chernobyl
and the future: too soon for a final diagnosis.
Williams D, Baverstock K.
Nature. 2006 Apr 20;440(7087):993-4.
Chromosomal
fragile sites FRA3B and FRA16D show correlated expression
and association with failure of apoptosis in lymphocytes
from patients with thyroid cancer.
Sbrana I, Veroni F, Nieri M, Puliti A, Barale R.
Genes Chromosomes Cancer. 2006 May;45(5):429-36.
Individual
thyroid dose estimates for a case-control study of chernobyl-related
thyroid cancer among children of Belarus--part II. Contributions
from long-lived radionuclides and external radiation.
Minenko VF, Ulanovsky AV, Drozdovitch VV, Shemiakina EV,
Gavrilin YI, Khrouch VT, Shinkarev SM, Voillequé PG, Bouville
A, Anspaugh LR, Luckyanov N.
Health Phys. 2006 Apr;90(4):312-27.
TP53
codon 72 polymorphism in radiation-associated human papillary
thyroid cancer.
Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA,
Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova
MV, Petoukhova NS, Tchebotareva IV, Ivanov VK, Chekin
SY, Bogdanova TI, Tronko MD, Tsyb AF, Thomas GA, Yamashita
S.
Oncol Rep. 2006 Apr;15(4):949-56.
Thyroid
cancer among Ukrainians and Belarusians who were children
or adolescents at the time of the Chernobyl accident.
Jacob P, Bogdanova TI, Buglova E, Chepurniy M, Demidchik
Y, Gavrilin Y, Kenigsberg J, Kruk J, Schotola C, Shinkarev
S, Tronko MD, Vavilov S.
J Radiol Prot. 2006 Mar;26(1):51-67.
Thyroid
disease 60 years after Hiroshima and 20 years after Chernobyl.
Boice JD Jr.
JAMA. 2006 Mar 1;295(9):1060-2. Erratum in: JAMA. 2006
Aug 2;296(5):518.
Using
total beta-activity measurements in milk to derive thyroid
doses from Chernobyl fallout.
Drozdovitch V, Germenchuk M, Bouville A.
Radiat Prot Dosimetry. 2006;118(4):402-11.
Increased
incidence of malignancies in Sweden after the Chernobyl
accident--a promoting effect?
Tondel M, Lindgren P, Hjalmarsson P, Hardell L, Persson
B.
Am J Ind Med. 2006 Mar;49(3):159-68.
Thyroid
cancer risk in areas of Ukraine and Belarus affected by
the Chernobyl accident.
Jacob P, Bogdanova TI, Buglova E, Chepurniy M, Demidchik
Y, Gavrilin Y, Kenigsberg J, Meckbach R, Schotola C, Shinkarev
S, Tronko MD, Ulanovsky A, Vavilov S, Walsh L.
Radiat Res. 2006 Jan;165(1):1-8.